Bosentan can be an inducer of CYP3A and CYP2C9. As a result plasma concentrations of drugs metabolized by these two isozymes will be lessened when bosentan is coadministered.This is certainly an Open up Access report which permits unrestricted noncommercial use, provided the original do the job is correctly cited.Bosentan was therefore a sensible f